Back

Chemical inactivation of two non-enveloped viruses follows distinct molecular pathways

Narula, P.; Lokshman, M. K.; Pathak, S. B.; Mukherjee, S.; Banerjee, M.

2024-07-16 microbiology
10.1101/2024.07.16.603687 bioRxiv
Show abstract

Non-enveloped viruses, which lack a lipid envelope, typically display higher resistance to disinfectants, soaps and sanitizers compared to enveloped viruses. The capsids of these viruses are highly stable and symmetric protein shells that resist inactivation by commonly employed virucidal agents. This group of viruses include highly transmissible human pathogens such as Rotavirus, Poliovirus, Foot and Mouth Disease Virus, Norovirus and Adenovirus; thus, devising appropriate strategies for chemical disinfection is essential. We tested a mild combination of a denaturant, alcohol, and organic acid on two representative non-enveloped viruses - Human Adenovirus 5 (HAdV5) and Feline Calicivirus (FCV)- and evaluated the molecular pathway of capsid neutralization using biophysical methods. The transition temperatures signifying conformational shifts in the capsid were established in the presence and absence of chemical treatment using Differential Scanning Calorimetry (DSC), while the corresponding morphological alterations were visualized and correlated using Transmission Electron Microscopy (TEM). We found that while chemical treatment of purified HAdV5 particles resulted in increased thermal instability, followed by large scale particle aggregation; similar treatment of FCV particles resulted in complete collapse of the capsids. The distinct effects of the chemical treatment on the morphology of HAdV5 and FCV suggests that non-enveloped viruses with icosahedral geometry can follow different molecular pathways to inactivation. Further, while individual components of the chemical formulation caused significant damage to the capsids, a synergistic action of the whole formulation was evident against both non-enveloped viruses tested. Molecular level understanding of inactivation pathways may result in the design and development of effective mass-market formulations for rapid neutralization of non-enveloped viruses. HighlightsO_LIformulation consisting of 3.2% citric acid, 1% urea in 70% ethanol, pH4 effectively inactivates HAdV5 and FCV. C_LIO_LIinactivation pathways with complete formulation, are different for the two viruses. C_LIO_LIeffect of whole formulation is more effective compared to individual components. C_LI

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Journal of General Virology
53 papers in training set
Top 0.1%
15.1%
2
PLOS ONE
5266 papers in training set
Top 20%
8.9%
3
Viruses
332 papers in training set
Top 0.7%
6.2%
4
Virology
61 papers in training set
Top 0.2%
5.5%
5
Journal of Virology
499 papers in training set
Top 1%
5.2%
6
Antimicrobial Agents and Chemotherapy
187 papers in training set
Top 0.6%
4.8%
7
Microbiology Spectrum
469 papers in training set
Top 3%
4.8%
50% of probability mass above
8
Applied and Environmental Microbiology
339 papers in training set
Top 2%
4.0%
9
Pathogens
56 papers in training set
Top 0.2%
3.2%
10
PLOS Neglected Tropical Diseases
466 papers in training set
Top 2%
3.2%
11
mSphere
302 papers in training set
Top 2%
3.2%
12
Frontiers in Microbiology
427 papers in training set
Top 3%
3.2%
13
Virology Journal
32 papers in training set
Top 0.2%
2.6%
14
Virus Research
37 papers in training set
Top 0.3%
2.1%
15
Antiviral Research
50 papers in training set
Top 0.3%
2.1%
16
Scientific Reports
3612 papers in training set
Top 47%
2.1%
17
Vaccines
198 papers in training set
Top 2%
1.7%
18
Access Microbiology
25 papers in training set
Top 0.3%
1.4%
19
Journal of Medical Virology
140 papers in training set
Top 2%
1.3%
20
Journal of Hospital Infection
29 papers in training set
Top 0.4%
1.0%
21
ACS Infectious Diseases
82 papers in training set
Top 2%
0.8%
22
Molecules
39 papers in training set
Top 1%
0.8%
23
Cureus
68 papers in training set
Top 5%
0.8%
24
Journal of Lipid Research
39 papers in training set
Top 0.6%
0.8%
25
Frontiers in Cellular and Infection Microbiology
109 papers in training set
Top 4%
0.6%
26
Journal of Clinical Microbiology
130 papers in training set
Top 2%
0.6%
27
American Journal of Infection Control
12 papers in training set
Top 0.3%
0.6%
28
Antibody Therapeutics
16 papers in training set
Top 0.3%
0.6%